Published : Jul-2018
No. of Pages : 334
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Endocrinology Tests Overview 15
3 Products under Development 16
3.1 Endocrinology Tests - Pipeline Products by Stage of Development 16
3.2 Endocrinology Tests - Pipeline Products by Segment 17
3.3 Endocrinology Tests - Pipeline Products by Territory 19
3.4 Endocrinology Tests - Pipeline Products by Regulatory Path 20
3.5 Endocrinology Tests - Pipeline Products by Estimated Approval Date 21
4 Endocrinology Tests - Pipeline Products under Development by Companies 22
4.1 Endocrinology Tests Companies - Pipeline Products by Stage of Development 22
4.2 Endocrinology Tests - Pipeline Products by Stage of Development 25
5 Endocrinology Tests Companies and Product Overview 31
5.1 Abbott Diagnostics Company Overview 31
5.2 AgPlus Diagnostics LTD Company Overview 33
5.3 Albert Einstein College of Medicine Company Overview 34
5.4 Alere Inc Company Overview 36
5.5 AMS Diagnostics LLC Company Overview 37
5.6 Aura Biotechnologies Pvt Ltd Company Overview 39
5.7 AXO Science SAS Company Overview 40
5.8 Beckman Coulter Inc Company Overview 41
5.9 Boditech Med Inc Company Overview 47
5.10 Canon Medical Systems Corp Company Overview 48
5.11 Carolina Liquid Chemistries Corp Company Overview 49
5.12 Celmatix Inc Company Overview 51
5.13 Ceres Nanosciences Inc Company Overview 52
5.14 China Medical Technologies Inc (Inactive) Company Overview 53
5.15 Columbia University Company Overview 54
5.16 Denka Seiken Co Ltd Company Overview 55
5.17 DiaSorin SpA Company Overview 56
5.18 DIAsource ImmunoAssays SA Company Overview 60
5.19 EDP Biotech Corporation Company Overview 61
5.20 Ellume Company Overview 62
5.21 Fujirebio Diagnostics Inc Company Overview 63
5.22 GeneFluidics Inc Company Overview 73
5.23 Genovum Sp. z o.o. Company Overview 76
5.24 Hebrew University of Jerusalem Company Overview 77
5.25 Immunodiagnostic Systems Holdings plc Company Overview 79
5.26 Intermountain Healthcare Inc Company Overview 84
5.27 King's College London Company Overview 85
5.28 Laboratoire HRA Pharma SAS Company Overview 86
5.29 Labsystems Diagnostics Oy Company Overview 87
5.30 Lucine Biotechnology, Inc. Company Overview 90
5.31 MDNA Life Sciences Inc Company Overview 91
5.32 MedMira Inc Company Overview 92
5.33 Mindray Medical International Ltd Company Overview 93
5.34 MyHealthTest Pty Ltd Company Overview 102
5.35 Northwestern University Company Overview 103
5.36 Novartis AG Company Overview 105
5.37 Oasis Diagnostics Corp Company Overview 107
5.38 Ohmx Corp Company Overview 108
5.39 OJ-Bio Ltd Company Overview 109
5.40 Orangelife Company Overview 110
5.41 Ortho-Clinical Diagnostics Inc Company Overview 111
5.42 Otsuka Pharmaceutical Co Ltd Company Overview 112
5.43 Paramedical Srl Company Overview 113
5.44 PerkinElmer Inc Company Overview 115
5.45 Proteomika Company Overview 116
5.46 QuickCheck Health Inc Company Overview 117
5.47 Quidel Corp Company Overview 118
5.48 Roche Diagnostics International Ltd Company Overview 120
5.49 Sendera Discovery Company Overview 133
5.50 Shahid Beheshti University Company Overview 134
5.51 Siemens Healthcare GmbH Company Overview 135
5.52 SomaLogic Inc Company Overview 155
5.53 Swan Diagnostics Ltd Company Overview 156
5.54 Sysmex Corp Company Overview 157
5.55 Tecan Group Ltd Company Overview 160
5.56 Thermo Fisher Scientific Inc Company Overview 162
5.57 Tosoh Bioscience Inc Company Overview 164
5.58 University of Edinburgh Company Overview 165
5.59 University of Michigan Company Overview 166
5.60 University of Otago Company Overview 167
5.61 University Rovira i Virgili Company Overview 168
6 Endocrinology Tests- Recent Developments 169
6.1 Jun 21, 2018: Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer 169
6.2 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 170
6.3 Jun 19, 2018: Sera Prognostics Collaborates with Christiana Care Health System to Launch New Preterm Birth Study with PreTRM Test 174
6.4 Jun 13, 2018: Alfa Wassermann Diagnostic Technologies Honored for Delivering World-Class' Customer Service 175
6.5 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 175
6.6 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 176
6.7 May 31, 2018: Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH 177
6.8 May 29, 2018: Intermountain Healthcare Launches New Study to Determine Benefit of Proactive Interventions in Reducing Premature Births 177
6.9 May 16, 2018: Novartis announces changes to the Executive Committee 179
6.10 May 16, 2018: At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth 180
6.11 May 10, 2018: Novartis India reconstitutes Board appoints Milan Paleja as Vice Chairman Managing Director 181
6.12 May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 181
6.13 May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 183
6.14 May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 186
6.15 May 08, 2018: Quidel Announces First Quarter 2018 Financial Results 189
6.16 May 08, 2018: Aeterna Zentaris Announces Results of Annual and Special Shareholders' Meeting 190
6.17 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future 191
6.18 May 07, 2018: Luminex Announces First Quarter 2018 Financial Results 192
6.19 May 07, 2018: Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results 192
6.20 May 03, 2018: Siemens Healthineers fully on track to meet the targets 194
6.21 May 02, 2018: Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 6% in local currencies in the first three months of 2018 195
6.22 May 01, 2018: Veracyte Reports First Quarter 2018 Financial Results 196
7 Appendix 329
7.1 Methodology 329
7.2 About GlobalData 332
7.3 Contact Us 332
7.4 Disclaimer 332
1.1 List of Tables
Table 1: Endocrinology Tests - Pipeline Products by Stage of Development 18
Table 2: Endocrinology Tests - Pipeline Products by Segment 19
Table 3: Endocrinology Tests - Pipeline Products by Territory 21
Table 4: Endocrinology Tests - Pipeline Products by Regulatory Path 22
Table 5: Endocrinology Tests - Pipeline Products by Estimated Approval Date 23
Table 6: Endocrinology Tests Companies - Pipeline Products by Stage of Development 24
Table 7: Endocrinology Tests - Pipeline Products by Stage of Development 27
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 33
Table 9: Alinity ci - Hormone Deficiency - Product Status 33
Table 10: Alinity ci - Hormone Deficiency - Product Description 33
Table 11: Alinity ci - Thyroid Disease - Product Status 34
Table 12: Alinity ci - Thyroid Disease - Product Description 34
Table 13: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 35
Table 14: AgPlus Diagnostic System - Testosterone Assay - Product Status 35
Table 15: AgPlus Diagnostic System - Testosterone Assay - Product Description 35
Table 16: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 36
Table 17: Cortisol Assay - Product Status 36
Table 18: Cortisol Assay - Product Description 36
Table 19: Estradiol Assay - Product Status 37
Table 20: Estradiol Assay - Product Description 37
Table 21: Progesterone Assay - Product Status 37
Table 22: Progesterone Assay - Product Description 37
Table 23: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 24: Vitamin D Assay - Product Status 38
Table 25: Vitamin D Assay - Product Description 38
Table 26: AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 27: LIASYS 330 - Vitamin D Assay - Product Status 39
Table 28: LIASYS 330 - Vitamin D Assay - Product Description 39
Table 29: Liasys 450 - Vitamin D Assay - Product Status 39
Table 30: Liasys 450 - Vitamin D Assay - Product Description 40
Table 31: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 32: AURA Quant Anti-Mullerian hormone (AMH) ELISA Kit - Product Status 41
Table 33: AURA Quant Anti-Mullerian hormone (AMH) ELISA Kit - Product Description 41
Table 34: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 42
Table 35: Multiplexed Detection - TSH - Product Status 42
Table 36: Multiplexed Detection - TSH - Product Description 42
Table 37: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 38: Access 2 Immunoassay System - Sensitive Estradiol - Product Status 43
Table 39: Access 2 Immunoassay System - Sensitive Estradiol - Product Description 44
Table 40: UniCel DxC 660i Synchron Access Clinical System - AMH Assay - Product Status 44
Table 41: UniCel DxC 660i Synchron Access Clinical System - AMH Assay - Product Description 44
Table 42: UniCel DxI 600 Access Immunoassay System - AMH Assay - Product Status 44
Table 43: UniCel DxI 600 Access Immunoassay System - AMH Assay - Product Description 45
Table 44: UniCel DxI 600 Access Immunoassay System - Sensitive Estradiol Assay - Product Status 45
Table 45: UniCel DxI 600 Access Immunoassay System - Sensitive Estradiol Assay - Product Description 45
Table 46: UniCel DxI 600 Access Immunoassay System - TSH (3rd IS) Assay - Product Status 45
Table 47: UniCel DxI 600 Access Immunoassay System - TSH (3rd IS) Assay - Product Description 46
Table 48: UniCel DxI 800 Access Immunoassay System - AMH Assay - Product Status 46
Table 49: UniCel DxI 800 Access Immunoassay System - AMH Assay - Product Description 46
Table 50: UniCel DxI 800 Access Immunoassay System - Sensitive Estradiol Assay - Product Status 46
Table 51: UniCel DxI 800 Access Immunoassay System - Sensitive Estradiol Assay - Product Description 47
Table 52: UniCel DxI 800 Access Immunoassay System - TSH (3rd IS) Assay - Product Status 47
Table 53: UniCel DxI 800 Access Immunoassay System - TSH (3rd IS) Assay - Product Description 47
Table 54: UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay - Product Status 47
Table 55: UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay - Product Description 48
Table 56: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 57: AFIAS-6 Progesterone Assay - Product Status 49
Table 58: AFIAS-6 Progesterone Assay - Product Description 49
Table 59: Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 50
Table 60: Diagnostic Test - Thyroid Disorders - Product Status 50
Table 61: Diagnostic Test - Thyroid Disorders - Product Description 50
Table 62: Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 51
Table 63: CLC 480 Analyzer - Vitamin D Assay - Product Status 51
Table 64: CLC 480 Analyzer - Vitamin D Assay - Product Description 51
Table 65: CLC 720i Analyzer - Vitamin D Assay - Product Status 52
Table 66: CLC 720i Analyzer - Vitamin D Assay - Product Description 52
Table 67: Celmatix Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 68: FertilArray - Product Status 53
Table 69: FertilArray - Product Description 53
Table 70: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 71: Nanotrap Human Growth Hormone Test - Product Status 54
Table 72: Nanotrap Human Growth Hormone Test - Product Description 54
Table 73: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55
Table 74: Infertility Reagent Test kit - ECLIA Analyzer - Product Status 55
Table 75: Infertility Reagent Test kit - ECLIA Analyzer - Product Description 55
Table 76: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 56
Table 77: Diagnostic Test - Menopause - Product Status 56
Table 78: Diagnostic Test - Menopause - Product Description 56
Table 79: Denka Seiken Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
Table 80: Adiponectin Assay Kit - Product Status 57
Table 81: Adiponectin Assay Kit - Product Description 57
Table 82: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 58
Table 83: Estradiol II Assay - Product Status 58
Table 84: Estradiol II Assay - Product Description 58
Table 85: LIAISON - High Sclerostin Assay - Product Status 59
Table 86: LIAISON - High Sclerostin Assay - Product Description 59
Table 87: LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Status 59
Table 88: LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Description 60
Table 89: LIAISON XL - Sclerostin Assay - Product Status 60
Table 90: LIAISON XL - Sclerostin Assay - Product Description 60
Table 91: Progesterone II Assay - Product Status 61
Table 92: Progesterone II Assay - Product Description 61
Table 93: DIAsource ImmunoAssays SA Pipeline Products & Ongoing Clinical Trials Overview 62
Table 94: 25-OH Vitamin D Total ELISA Test - Product Status 62
Table 95: 25-OH Vitamin D Total ELISA Test - Product Description 62
Table 96: EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 63
Table 97: Diagnostic Assay - Early Conception Factor - Product Status 63
Table 98: Diagnostic Assay - Early Conception Factor - Product Description 63
Table 99: Ellume Pipeline Products & Ongoing Clinical Trials Overview 64
Table 100: ESP-Based Diagnostic Test - Pregnancy - Product Status 64
Table 101: ESP-Based Diagnostic Test - Pregnancy - Product Description 64
Table 102: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 103: Lumipulse G - AFP Assay - Product Status 65
Table 104: Lumipulse G - AFP Assay - Product Description 66
Table 105: Lumipulse G - FT3 Assay - Product Status 66
Table 106: Lumipulse G - FT3 Assay - Product Description 66
Table 107: Lumipulse G - FT4 Assay - Product Status 67
Table 108: Lumipulse G - FT4 Assay - Product Description 67
Table 109: Lumipulse G - T3 Assay - Product Status 67
Table 110: Lumipulse G - T3 Assay - Product Description 68
1.2 List of Figures
Figure 1: Endocrinology Tests - Pipeline Products by Stage of Development 18
Figure 2: Endocrinology Tests - Pipeline Products by Segment 19
Figure 3: Endocrinology Tests - Pipeline Products by Territory 21
Figure 4: Endocrinology Tests - Pipeline Products by Regulatory Path 22
Figure 5: Endocrinology Tests - Pipeline Products by Estimated Approval Date 23
